December 6, 2009Open Access

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Structured PICO

Does a fixed dose of dabigatran provide similar efficacy and safety compared to warfarin in the treatment of acute venous thromboembolism?

Population

Patients with acute venous thromboembolism

Intervention

Fixed dose of dabigatran

Comparator

Warfarin

A fixed dose of dabigatran is as effective and safe as warfarin for treating acute venous thromboembolism, with the added benefit of not requiring laboratory monitoring.

Abstract

For the treatment of acute venous thromboembolism, a fixed dose of dabigatran is as effective as warfarin, has a safety profile that is similar to that of warfarin, and does not require laboratory monitoring. (ClinicalTrials.gov number, NCT00291330.)

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Sam Schulman

Clive Kearon

Ajay K. Kakkar

Journals

New England Journal of Medicine

Actions

Institutions

Harvard University

Brigham and Women's Hospital

McMaster University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Structured PICO

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider